Research has found an increase in the levels of GSK-3β and phosphorylated GSK-3β at Tyr216 in the frontal cortex and hippocampus of ALS patients (Yang et al., 2008). The gene discussed is GSK3B; the disease is amyotrophic lateral sclerosis.